- Home
- MRNA
MRNA
Moderna Inc.
as 11-01-2025 4:20am EST
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Upcoming Earnings Alert:
Get ready for potential market movements as Moderna Inc. MRNA prepares to release earnings report on 06 Nov 2025.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | CAMBRIDGE |
| Market Cap: | 9.8B | IPO Year: | 2018 |
| Target Price: | $37.15 | AVG Volume (30 days): | 10.8M |
| Analyst Decision: | Hold | Number of Analysts: | 15 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -7.53 | EPS Growth: | N/A |
| 52 Week Low/High: | $23.15 - $56.70 | Next Earning Date: | 11-06-2025 |
| Revenue: | $3,078,000,000 | Revenue Growth: | -39.05% |
| Revenue Growth (this year): | -40.27% | Revenue Growth (next year): | 11.12% |
Latest Moderna Inc. News
MRNA Breaking Stock News: Dive into MRNA Ticker-Specific Updates for Smart Investing
StockStory
21 days ago
Moderna (MRNA) Stock Trades Up, Here Is Why
MT Newswires
21 days ago
Moderna Says Investigational Cancer Antigen Therapy Shows 'Promising' Early Data
StockStory
21 days ago
3 Cash-Burning Stocks with Warning Signs
ACCESS Newswire
22 days ago
Moderna Presents Promising Early Data for Its Investigational Cancer Antigen Therapy at the 2025 European Society for Medical Oncology Congress
StockStory
24 days ago
10x Genomics, BioMarin Pharmaceutical, AMN Healthcare Services, Illumina, and Moderna Stocks Trade Down, What You Need To Know
Zacks
24 days ago
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
BioPharma Dive
24 days ago
AstraZeneca ups investment in Virginia; Moderna vets launch VC fund
Simply Wall St.
25 days ago
Should Moderna's (MRNA) Improved Revenue Trends Prompt New Action From Investors?
Compare MRNA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MRNA Moderna Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.